Muhammad Massarwa

514 total citations
14 papers, 386 citations indexed

About

Muhammad Massarwa is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Muhammad Massarwa has authored 14 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Muhammad Massarwa's work include Liver Disease Diagnosis and Treatment (5 papers), Liver Disease and Transplantation (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Muhammad Massarwa is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Liver Disease and Transplantation (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Muhammad Massarwa collaborates with scholars based in Israel and United States. Muhammad Massarwa's co-authors include Tawfik Khoury, Ariel A. Benson, Saleh Daher, Jakob A. Shimshoni, Rifaat Safadi, Mikhail Borisover, Shimon Barel, Yaira Chen, David Hakimian and Mahmud Mahamid and has published in prestigious journals such as PLoS ONE, Alimentary Pharmacology & Therapeutics and Journal of Gastroenterology and Hepatology.

In The Last Decade

Muhammad Massarwa

13 papers receiving 377 citations

Peers

Muhammad Massarwa

HEPAT

EPIDE

ONCOL

SURGE

Ruichuang Yang China

András Vida Hungary

David Díaz-Carballo Germany

Deniz Tümen Germany

Jiandong Yu China

Umesh Hanumegowda United States

Viktoriia A. Arzumanian Russia

Ruichuang Yang China

Muhammad Massarwa

275 ×2.4

76 ×0.8

HEPAT

66 ×0.8

EPIDE

101 ×1.6

ONCOL

40 ×0.7

SURGE

Citations per year, relative to Muhammad Massarwa Muhammad Massarwa (= 1×) peers Ruichuang Yang

Countries citing papers authored by Muhammad Massarwa

Since Specialization

Citations

This map shows the geographic impact of Muhammad Massarwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Massarwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Massarwa more than expected).

Fields of papers citing papers by Muhammad Massarwa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Massarwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Massarwa. The network helps show where Muhammad Massarwa may publish in the future.

Co-authorship network of co-authors of Muhammad Massarwa

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Massarwa. A scholar is included among the top collaborators of Muhammad Massarwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Massarwa. Muhammad Massarwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Amer, Johnny, Yael Milgrom, Muhammad Massarwa, et al.. (2025). Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes. Pharmaceuticals. 18(7). 1075–1075. 2 indexed citations

Imam, Ashraf, Johnny Amer, Yael Milgrom, et al.. (2025). SGLT2 Inhibitors in MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) Associated with Sustained Hepatic Benefits, Besides the Cardiometabolic. Pharmaceuticals. 18(8). 1118–1118.

Milgrom, Yael, et al.. (2024). [TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)].. PubMed. 163(2). 93–96. 2 indexed citations

Amer, Johnny, David Hakimian, Yael Milgrom, et al.. (2022). Advanced Liver Fibrosis Correlates With Impaired Efficacy of Pfizer‐BioNTech COVID‐19 Vaccine in Medical Employees. Hepatology Communications. 6(6). 1278–1288. 6 indexed citations

Levite, Mia, Rifaat Safadi, Yael Milgrom, Muhammad Massarwa, & Eithan Galun. (2021). Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cells. Neuropeptides. 89. 102159–102159. 7 indexed citations

Hakimian, David, Ariel A. Benson, Tawfik Khoury, et al.. (2021). Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study. BMC Gastroenterology. 21(1). 274–274. 3 indexed citations

Safadi, Rifaat, Marius Braun, Yael Milgrom, et al.. (2021). Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis. Alimentary Pharmacology & Therapeutics. 54(11-12). 1405–1415. 28 indexed citations

Shimshoni, Jakob A., et al.. (2019). Pesticide distribution and depletion kinetic determination in honey and beeswax: Model for pesticide occurrence and distribution in beehive products. PLoS ONE. 14(2). e0212631–e0212631. 41 indexed citations

Khoury, Tawfik, Saleh Daher, Muhammad Massarwa, et al.. (2019). A Validated Score Assessing the Risk of an Intra-Abdominal Abscess in Patients with Crohn’s Disease Presenting at the Emergency Department. Journal of Crohn s and Colitis. 13(9). 1131–1137. 10 indexed citations

10.

Daher, Saleh, et al.. (2018). Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. PLoS ONE. 13(11). e0207479–e0207479. 3 indexed citations

11.

Khoury, Tawfik, Muhammad Massarwa, Saleh Daher, et al.. (2018). Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients. Journal of Gastrointestinal Cancer. 50(4). 759–762. 1 indexed citations

12.

Khoury, Tawfik, Meir Mizrahi, Mahmud Mahamid, et al.. (2018). State of the art review with literature summary on gastric peroral endoscopic pyloromyotomy for gastroparesis. Journal of Gastroenterology and Hepatology. 33(11). 1829–1833. 25 indexed citations

13.

Khoury, Tawfik, Muhammad Massarwa, Saleh Daher, et al.. (2018). Endoscopic Ultrasound‐Guided Angiotherapy for Gastric Varices: A Single Center Experience. Hepatology Communications. 3(2). 207–212. 16 indexed citations

14.

Daher, Saleh, Muhammad Massarwa, Ariel A. Benson, & Tawfik Khoury. (2017). Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review. Journal of Clinical and Translational Hepatology. 6(1). 1–10. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruichuang Yang Breakdown of academic impact, for papers by András Vida Breakdown of academic impact, for papers by David Díaz-Carballo Breakdown of academic impact, for papers by Deniz Tümen Breakdown of academic impact, for papers by Jiandong Yu Breakdown of academic impact, for papers by Umesh Hanumegowda Breakdown of academic impact, for papers by Viktoriia A. Arzumanian